5th Edition of International Conference on Tissue Engineering and Regenerative Medicine
September 18-20 | London, UK
Ethical, Regulatory, and Commercial Aspects
The advancement of regenerative technologies demands careful alignment with societal values, legal frameworks, and business viability. Ethical, regulatory, and commercial aspects address questions of patient consent, long-term safety, equitable access, and sustainability of emerging therapies. The global expansion of clinical trials and biotechnological innovation calls for harmonized approval processes and transparent standards. Commercial strategies must balance profitability with public good, encouraging innovation while maintaining accountability. Ethical, regulatory, and commercial aspects also include intellectual property rights, pricing models, and education for both clinicians and patients. Navigating this complex terrain is essential for responsible translation of regenerative science into accessible and ethically sound healthcare solutions.
Thomas J Webster
Interstellar Therapeutics, United States
Nagy Habib
Imperial College London, United Kingdom
Alexander Seifalian
Nanotechnology & Regenerative Medicine Commercialisation Centre, London NW1 0NH, United Kingdom
Vasiliki E Kalodimou
Director Flow Cytometry-Research, Greece
Kunal Mitra
Florida Tech, United States
Celine Van Der Valk
Leiden University of Applied Sciences, Netherlands
Lucie Bacakova
Institute of Physiology of the Czech Academy of Sciences, Czech RepublicSubmit your abstract Today
Title : Eliminating implants infections with nanomedicine: Human results
Thomas J Webster, Interstellar Therapeutics, United States
Title : Graphene, butterfly structures, and stem cells: A revolution in surgical implants
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, London NW1 0NH, United Kingdom
Title : Biodistribution and gene targeting in regenerative medicine
Nagy Habib, Imperial College London, United Kingdom
Title : Precision in cartilage repair: Breakthroughs in biofabrication process optimization
Pedro Morouco, Polytechnic of Leiria, Portugal
Title : AI-integrated high-throughput tissue-chip for brain aging
Kunal Mitra, Florida Tech, United States
Title : Assembly and stability of on-chip microvasculature
Kara E McCloskey, University of California, Merced, United States